A Single Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-42165279 in Healthy Male Participants

Clinical trial NCT01650597 · COMPLETED

Trial details

NCT number: NCT01650597
Sponsor: Janssen-Cilag International NV
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers Pharmacokinetics

Start date: 2011-08-01
Primary completion: 2012-05-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.